Orbital Exenteration: A Dilemma in Mucormycosis Presented with Orbital Apex Syndrome

Background Mucormycosis is an uncommon, rapidly progressive, commonly fatal, opportunistic, fungal paranasal sinus infection. The most critical decision in the management of rhino-orbital mucormycosis is whether the orbit should be exenterated. The literature fails to provide a broad base of information of how physicians determine the need for exenteration in daily practice. The decision for exenteration often depends on the judgment of the treating otolaryngologist. The authors report their experience and outline that orbital exenteration may not be mandatory in all cases of rhino-orbital mucormycosis. Methods The medical records from Celal Bayar University Medical Faculty Department of Otorhinolaryngology/Head and Neck Surgery were retrospectively searched from 1995 to 2007 for three cases with rhino-orbital mucormycosis, treated without orbital exenteration. Results All patients with rhino-orbital mucormycosis who were treated without exenteration survived. Conclusion The favorable outcome was attributable to rapid correction of the underlying medical condition; wide local excision and debridement of all involved and devitalized sinonasal and periorbital tissue, while establishing adequate sinus and orbital drainage; daily endoscopic assessment with multiple sinus debridement when necessary; daily irrigation of the involved areas; and high-dose i.v. amphotericin B.

[1]  B. Haik,et al.  Indications for Orbital Exenteration in Mucormycosis , 2006, Ophthalmic plastic and reconstructive surgery.

[2]  P. Borghei,et al.  Rhinocerebral mucormycosis: pathways of spread , 2005, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[3]  C. Goktan,et al.  Rhinocerebral mucormycosis: Perineural spread via the trigeminal nerve , 2005, Journal of Clinical Neuroscience.

[4]  Dr. Arnold Paltauf Mycosis mucorina , 1885, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[5]  S. Yeh,et al.  Orbital apex syndrome , 2004, Current opinion in ophthalmology.

[6]  S. Bhadada,et al.  Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes , 2004, Postgraduate Medical Journal.

[7]  L. Pagano,et al.  Mucormycosis in hematologic patients. , 2004, Haematologica.

[8]  A. Thakar,et al.  Improving outcomes in rhinocerebral mucormycosis - early diagnostic pointers and prognostic factors , 2003, The Journal of Laryngology & Otology.

[9]  Reji Thomas,et al.  Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. , 2003, Indian journal of ophthalmology.

[10]  H. S. Dökmetaş,et al.  Diabetic ketoacidosis and rhino-orbital mucormycosis. , 2002, Diabetes research and clinical practice.

[11]  S. Lad,et al.  Fatal rhino-orbito-cerebral mucormycosis in an apparently normal host: case report and literature review , 2001, Journal of Clinical Neuroscience.

[12]  N. Newman,et al.  Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. , 2001, American journal of ophthalmology.

[13]  B. Patel,et al.  Successful Treatment of Rhino-orbital Mucormycosis Without Exenteration: The Use of Multiple Treatment Modalities , 2001, Ophthalmic plastic and reconstructive surgery.

[14]  R. Lewandowski,et al.  Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. , 2000, Ophthalmology.

[15]  J. Olshaker,et al.  Rhinocerebral mucormycosis: a case of a rare, but deadly disease. , 1999, The Journal of emergency medicine.

[16]  L. Pagano,et al.  Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases , 1997, British journal of haematology.

[17]  E. Abemayor,et al.  Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options , 1997, The Laryngoscope.

[18]  C. Juárez,et al.  Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. , 1996, Ophthalmic surgery and lasers.

[19]  R. Jooma,et al.  Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. , 1995, European journal of radiology.

[20]  D. Dooley,et al.  Indolent orbital apex syndrome caused by occult mucormycosis. , 1992, Journal of clinical neuro-ophthalmology.

[21]  D. Underwood,et al.  MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. , 1992, Magnetic resonance imaging.

[22]  N. Gülekon,et al.  Rhinocerebral mucormycosis with extension to the cavernous sinus. A case report. , 1991, Rhinology.

[23]  A. Cheesman,et al.  Rhinocerebral mucormycosis: Use of liposomal amphotericin B , 1991, The Journal of Laryngology & Otology.

[24]  P. Reményi,et al.  MUCORMYCOSIS , 1986, The Lancet.

[25]  R. Hepler,et al.  Management of limited rhino-orbital mucormycosis without exenteration. , 1985, Ophthalmology.

[26]  S. Lippman,et al.  Computed tomographic findings in orbital Mucor. , 1985, The Western journal of medicine.

[27]  S. Abedi,et al.  Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. , 1983, Ophthalmology.

[28]  A. Blitzer,et al.  Patient survival factors in paranasal sinus mucormycosis , 1980, The Laryngoscope.

[29]  A. Schleuning,et al.  Mucormycosis of the nose and paranasal sinuses. , 1965, The Laryngoscope.

[30]  D. Borland Mucormycosis of the central nervous system. , 1959, A.M.A. journal of diseases of children.

[31]  J. Harris Mucormycosis; report of a case. , 1955, Pediatrics.

[32]  J. Vandeputte,et al.  Amphotericins A and B, antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins. , 1955, Antibiotics annual.